Molecular Templates, Inc. announced that they will present a poster on interim clinical results for the MT-5111 program at the San Antonio Breast Cancer Symposium (SABCS) which will take place December 6 â December 10, 2022 at the Henry B. Gonzalez Convention Center in San Antonio, TX.Molecular Templates will also participate in one-on-one meetings at the 64thAmerican Society of Hematology (ASH) Annual Meeting which will take place December 10 â December 13, 2022 at the Ernest N. Morial Convention Center in New Orleans, LA. In-person and virtual meetings may be scheduled directly with Molecular Templates.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.55 USD | -3.12% | -10.14% | -58.45% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-58.45% | 10.53M | |
+2.90% | 108B | |
+10.28% | 105B | |
+1.57% | 23.46B | |
-12.32% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.41% | 17.19B | |
+6.26% | 13.99B | |
+37.00% | 12.53B |
- Stock Market
- Equities
- MTEM Stock
- News Molecular Templates, Inc.
- Molecular Templates, Inc. to Present Interim Results on MT-5111 at the 45th Annual San Antonio Breast Cancer Symposium and Participate at the 64th American Society of Hematology Annual Meeting